USFDA clears Lupin's Goa facility; stocks up 6.25%
Pharma firm Lupin has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility regarding a inspection done by the USFDA in July last year.
Jul 07, 2016, 17:08 PM IST